NCT05131022 2026-03-16A Study of NX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesNurix Therapeutics, Inc.Phase 1 Recruiting572 enrolled
NCT05024045 2026-03-03Study of Oral LOXO-338 in Patients With Advanced Blood CancersEli Lilly and CompanyPhase 1 Active not recruiting316 enrolled
NCT07424833 2026-02-20A Study of APG-3288 in Relapsed/Refractory Blood CancersAscentage Pharma Group Inc.Phase 1 Not yet recruiting180 enrolled
NCT04775745 2026-02-13Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.Newave Pharmaceutical IncPhase 1 Recruiting60 enrolled
NCT05544019 2026-02-13Study of SGR-1505 in Mature B-Cell NeoplasmsSchrödinger, Inc.Phase 1 Recruiting98 enrolled
NCT05753501 2026-01-27Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesAbbViePhase 1 Recruiting340 enrolled